The Vitamin D–Dementia Connection
A new study published in Neurology Open Access is making headlines - and for good reason. Researchers found that people with higher vitamin D levels in their 30s and 40s were more likely to have lower tau protein levels in their brains decades later.¹ Tau is one of the key hallmark proteins associated with Alzheimer's disease. The study followed 793 people over 16 years, and the findings are adding to a growing body of evidence that vitamin D does far more for the human body than keep bones strong.
But what the headlines aren't fully explaining is why.
It starts with the immune system
Vitamin D isn't just a nutrient. It is a hormone, and its receptors are found on virtually every cell of the immune system. That includes monocytes, macrophages, T lymphocytes, B lymphocytes, and natural killer cells.²'³ When vitamin D levels are adequate, these cells are better equipped to regulate inflammation, respond to pathogens, and maintain the kind of immune balance that protects tissue - including brain tissue - over time.
When vitamin D levels are chronically low, that regulatory capacity is compromised. The result is a weakened immune response to viruses and bacteria - a low-grade inflammatory environment that can quietly do damage over years and decades. Neuroinflammation - inflammation in and around the brain - is increasingly recognized as a driver of neurodegenerative conditions, including Alzheimer's disease.⁴'⁵ The connection to tau protein accumulation, while still being studied, is consistent with what immunologists have understood about vitamin D's systemic role for some time.
Basically, what the dementia researchers found is something immunologists weren't surprised by.
The midlife window matters
One of the most important details in this study is when vitamin D levels were measured: in participants' 30s and 40s. The tau protein findings showed up 15+ years later. This matters because the pathological processes associated with dementia, including the accumulation of tau and amyloid proteins, are known to begin 15 to 20 years before clinical symptoms of cognitive decline appear.⁶'⁷
Pay attention now - not later. If you are in your 30s or 40s and haven't thought about your vitamin D levels, this research is a reason to start.
Why Canadians need to take this especially seriously
An estimated 60% of the global population is vitamin D deficient.¹ In Canada, that number climbs significantly in winter months. Statistics Canada has reported that roughly 40% of Canadians fall below the threshold considered sufficient for bone health alone in winter.⁸ The picture for immune optimization is even more demanding.
The reason is geography. Canada's northern latitude means that for a significant portion of the year, the sun's UV rays are not strong enough for the skin to synthesize meaningful amounts of vitamin D, regardless of how much time you spend outdoors. Diet helps - fatty fish, egg yolks, and fortified dairy products contain some vitamin D - but most Western diets don't come close to filling the gap.
Supplementation is essential for the majority of Canadians. The question is how much, and that answer is not one-size-fits-all.
Why testing matters more than guessing
Standard supplementation guidelines exist for a reason, but they are built around population averages and bone health thresholds, not immune optimization. Research increasingly suggests the vitamin D levels needed to support robust immune function are higher than what conventional guidelines recommend.
There is also an important genetic dimension. Individual variation in the genes responsible for vitamin D synthesis in the skin (due to differences in pigmentation), transport, and metabolism - including CYP2R1, GC, and CYP24A1 - means that two people taking the identical supplement dose can end up with very different blood levels.⁹'¹⁰ Some people process and utilize vitamin D efficiently; others do not. Without testing, there is no way to know which category you fall into.
At ImmunoCeutica, we have a straightforward position on this: test, don't guess. A simple blood test measuring your 25-hydroxyvitamin D level tells you where you actually stand. From there, supplementation can be tailored to your individual baseline - not a population average.
What this means in practice
The dementia study adds meaningful weight to a conversation that extends well beyond Alzheimer's risk. Low vitamin D levels have now been associated with increased risk of cardiovascular events, autoimmune conditions, respiratory illness, helps minmize the negative effects of osteoporosis particularly around menopause, which is also a problem associated with aging, and impaired immune response more broadly.⁵ The immune system underpins all of it.
If you haven't tested your vitamin D levels, now is a good time. If you have, and your levels are low, work with your healthcare provider on a supplementation plan that reflects where you actually need to be - not just the minimum threshold to avoid deficiency.
Your immune system is working for you every day. Give it what it needs.
Reviewed by Dr. Lauri Wegter-Lesperance, PhD, and Emily Dutka, MSC
References
-
- Mulligan MD, Scott MR, Yang Q, et al. Association of Circulating Vitamin D in Midlife With Increased Tau-PET Burden in Dementia-Free Adults. Neurology Open Access. April 1, 2026. DOI: 10.1212/WN9.0000000000000057
- Bhalla AK, et al. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983;57(6):1308–10.
- Vanherwegen AS, Gysemans C, Mathieu C. Regulation of immune function by vitamin D and its use in diseases of immunity. Endocrinol Metab Clin North Am. 2017;46(4):1061–1094.
- Landel V, et al. Vitamin D as a Modulator of Neuroinflammation: Implications for Brain Health. PubMed. 2024. PMID: 38303529
- Tieu S, Charchoglyan A, Wagter-Lesperance L, et al. Immunoceuticals: Harnessing Their Immunomodulatory Potential to Promote Health and Wellness. Nutrients. 2022;14(19):4075. DOI: 10.3390/nu14194075
- ScienceDirect. Unraveling tau's fold: Structural dynamics in Alzheimer's pathogenesis. 2025. DOI: 10.1016/B978-0-443-23632-0-00063-X
- National Institute on Aging. Estimates of amyloid onset may predict Alzheimer's progression. Published February 2023. https://www.nia.nih.gov/news/estimates-amyloid-onset-may-predict-alzheimers-progression
- Statistics Canada. Vitamin D blood levels of Canadians. Catalogue no. 82-624-X. https://www150.statcan.gc.ca/n1/pub/82-624-x/2013001/article/11727-eng.htm
- Karrow NA, Leuschner SE, Shandilya UK, Mallard BA, Wagter-Lesperance L, Bridle BW. Genetic Variants Influencing Individual Vitamin D Status. Nutrients. 2025;17(16):2673. DOI: 10.3390/nu17162673
- Slater NA, Rager ML, Havrda DE, Harralson AF. Genetic Variation in CYP2R1 and GC Genes Associated With Vitamin D Deficiency Status. J Pharm Pract. 2015.